SPARK Biopharma, Inc.
PrivateLast Round
Private Equity
May 11, 2026
Est. Valuation
$141.75M
Total Funding Raised
$70.23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SPARK Biopharma, Inc. is a biotechnology company that develops small-molecule therapeutics using phenotypic discovery platforms for the treatment of oncology, chronic inflammation, and immune disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SPARK Biopharma, Inc. Comparables
Compare SPARK Biopharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Octant | 78% | |
| Dalriada Drug Discovery | 71% | |
| Oncodesign Services | 69% | |
SPARK Biopharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 11, 2026 | ||||
| Series C | Apr 4, 2022 | ||||
| Strategic | Nov 25, 2021 | ||||
| Series B | Aug 26, 2019 | ||||
| Series A | Jul 1, 2018 |
SPARK Biopharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shinhan Venture Investment | Series C |
| KB Investment | Series C, Series B |
| KB Investment | Series C, Series B, Series A |
| SJG Partners | Private Equity |
| Timefolio Asset Management | Series C |
| Company K Partners | Series C, Series B |
| KTB Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
$23M round with participation from SJG Partners and Shinhan Capital.
- Apr 4, 2022
$20.25M round with participation from Dt& Investment and Kiwoom Investment.
SPARK Biopharma, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SPARK Biopharma, Inc.'s valuation, stock price, and market status.